12.91
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ATRA Giù?
Forum
Previsione
Atara Biotherapeutics Inc Azioni (ATRA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
82.09%
17.57
|
98.15 | 32.75 | 40.19 | 28.64 |
|
75.77%
14.38
|
59.35 | 44.96 | 61.95 | 46.87 |
Interest Income/Expense |
4.42%
0.972
|
1.017 | 1.017 | 1.183 | 1.262 |
Benefits Costs and Expenses |
74.75%
15.19
|
60.14 | 45.47 | 62.12 | 47.69 |
Costs And Expenses |
75.77%
14.38
|
59.35 | 44.96 | 61.95 | 46.87 |
Depreciation and Amortization |
86.85%
0.236
|
1.795 | 1.10 | 1.23 | 1.33 |
Operating Income/Loss |
91.76%
3.197
|
38.80 | -12.20 | -21.76 | -18.23 |
Income/Loss From Continuing Operations Before Tax |
93.71%
2.39
|
38.01 | -12.71 | -21.93 | -19.05 |
Income Tax Expense/Benefit |
0.003
|
- | -0.019 | -0.017 | - |
Income/Loss From Continuing Operations After Tax |
93.72%
2.387
|
38.01 | -12.69 | -21.91 | -19.05 |
|
93.72%
2.387
|
38.01 | -12.69 | -21.91 | -19.05 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
13.31%
12.20
|
10.76 | 1.074 | 7.466 | 6.143 |
Diluted Average Shares |
13.45%
12.31
|
10.85 | 1.074 | 7.466 | 6.143 |
Basic Earnings Per Share |
94.33%
0.20
|
3.53 | -0.07 | -2.93 | -3.10 |
Diluted Earnings Per Share |
94.57%
0.19
|
3.50 | -0.07 | -2.93 | -3.10 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):